You are here

Compliance With Treatment For Patients With Hyperlipidemia

Last updated on March 14, 2019

FOR MORE INFORMATION
Study Location
Pfizer Investigational Site
Akersberga, , 184 27 Sweden
Contact
1-800-718-1021
Eligibility criteria
Condition
The disease, disorder, syndrome, illness, or injury that is being studied.
Hyperlipidemia
Sex
Females and Males
Age
Pediatric Trials: 0-17 Years
Adult Trials: 18+ Years
18 + years
Inclusion criteria
The factors, or reasons, that allow a person to participate in a clinical study.
Show details

- Aged 18 years or older and able to understand and sign the informed consent form.

- Patients diagnosed with hyperlipidemia and a very high risk developing
cardiovascular disease prescribed statin treatment according to clinical praxis
and the recommendations set forth in the MPA national guideline for treatment of
hyperlipidemia.

Exclusion criteria
The factors, or reasons, that prevent a person from participating in a clinical study.
Show details

- Patients contraindicated for statin treatment according to market authorization for
these drugs should be excluded from the study.

- Patients participating in other clinical trials or non-interventional studies.

NCT00828945
Pfizer
Completed
Compliance With Treatment For Patients With Hyperlipidemia

NEED INFO?

Questions about a trial? Call or email to reach a Pfizer Clinical Trial Contact Center

Pfizer Clinical Trials Contact Center

1-800-718-1021

[email protected]

call now

Try a new search

Search for Clinical Trials by condition, keyword or trial number. Share your location or enter your city or zip code to find studies near you.

FOR MORE INFORMATION

Contact a representative by phone, email, or visiting the study website. Please see the references below:

BY PHONE

Pfizer Clinical Trials Contact Center

1-800-718-1021

BY EMAIL

Contact

[email protected]

Call Now